HighVista Strategies’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $914K | Sell |
69,723
-21,484
| -24% | -$282K | 0.34% | 113 |
|
|
2025
Q1 | $2.01M | Buy |
91,207
+8,475
| +10% | +$186K | 0.77% | 38 |
|
|
2024
Q4 | $2.21M | Sell |
82,732
-6,106
| -7% | -$163K | 0.82% | 37 |
|
|
2024
Q3 | $2.37M | Buy |
+88,838
| New | +$2.37M | 0.82% | 36 |
|
|
2023
Q1 | – | Sell |
-187,480
| Closed | -$1.68M | – | 115 |
|
|
2022
Q4 | $1.68M | Buy |
187,480
+84,018
| +81% | +$751K | 1% | 32 |
|
|
2022
Q3 | $1.02M | Hold |
103,462
| – | – | 0.58% | 41 |
|
|
2022
Q2 | $824K | Buy |
103,462
+43,729
| +73% | +$348K | 0.5% | 43 |
|
|
2022
Q1 | $579K | Buy |
+59,733
| New | +$579K | 0.37% | 67 |
|
|
2021
Q4 | – | Sell |
-39,133
| Closed | -$650K | – | 86 |
|
|
2021
Q3 | $650K | Buy |
39,133
+11,666
| +42% | +$194K | 0.43% | 65 |
|
|
2021
Q2 | $586K | Buy |
+27,467
| New | +$586K | 0.42% | 68 |
|